CIBMTR Reporting Implementation Guide
0.1.10 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.10 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.10: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/snomed-myelodysplastic-diseases-vs | Version: 0.1.10 | |||
| Draft as of 2026-04-23 | Computable Name: SNOMEDMyelodysplasticDiseasesVS | |||
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia (abnormal growth or development leading to an alteration in size, shape, and organization of the cell) in one or more of the major myeloid cell lines (WBC, RBC, and/or platelets), ineffective hematopoiesis, and an increased risk of developing acute myelogenous leukemia (AML). MDS occurs primarily in older adults, with a median age of 70 years. The majority of recipients present with symptoms related to cytopenias. Most recipients present with anemia requiring RBC transfusions.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://snomed.info/sct version Not Stated (use latest from terminology server) where concept is-a 109995007 (Myelodysplastic syndrome (clinical))
Expansion from tx.fhir.org based on SNOMED CT International edition 01-Feb 2025
This value set contains 15 concepts
| System | Code | Display (en) | JSON | XML |
http://snomed.info/sct | 109995007 | Myelodysplastic syndrome (clinical) | ||
http://snomed.info/sct | 109998009 | Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia | ||
http://snomed.info/sct | 277597005 | 5q minus syndrome | ||
http://snomed.info/sct | 307340003 | Monosomy 7 syndrome | ||
http://snomed.info/sct | 398623004 | Refractory anaemia with excess blasts | ||
http://snomed.info/sct | 415283002 | Refractory anemia with excess blasts-1 | ||
http://snomed.info/sct | 415284008 | Refractory anemia with excess blasts-2 | ||
http://snomed.info/sct | 705061009 | Childhood myelodysplastic syndrome | ||
http://snomed.info/sct | 721304007 | Refractory thrombocytopenia | ||
http://snomed.info/sct | 1177173001 | MYSM1 deficiency | ||
http://snomed.info/sct | 1260217004 | Myelodysplastic neoplasm with low blasts and SF3B1 mutation | ||
http://snomed.info/sct | 1260268001 | Myelodysplastic syndrome with low blasts | ||
http://snomed.info/sct | 1260270005 | Hypoplastic myelodysplastic syndrome | ||
http://snomed.info/sct | 1260406003 | Myelodysplastic neoplasm with biallelic TP53 inactivation | ||
http://snomed.info/sct | 1264416003 | Unclassifiable myelodysplastic syndrome |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |